GSA Capital Partners’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.35M | Buy |
643,744
+367,037
| +133% | +$767K | 0.09% | 287 |
|
2025
Q1 | $472K | Buy |
276,707
+129,270
| +88% | +$221K | 0.04% | 842 |
|
2024
Q4 | $745K | Buy |
147,437
+27,119
| +23% | +$137K | 0.06% | 607 |
|
2024
Q3 | $655K | Sell |
120,318
-103,861
| -46% | -$565K | 0.05% | 734 |
|
2024
Q2 | $1.08M | Buy |
224,179
+25,130
| +13% | +$121K | 0.08% | 459 |
|
2024
Q1 | $619K | Sell |
199,049
-238,032
| -54% | -$740K | 0.05% | 759 |
|
2023
Q4 | $1.24M | Buy |
437,081
+81,163
| +23% | +$230K | 0.1% | 294 |
|
2023
Q3 | $1.04M | Buy |
355,918
+207,333
| +140% | +$608K | 0.09% | 371 |
|
2023
Q2 | $425K | Buy |
+148,585
| New | +$425K | 0.04% | 842 |
|